New dimensions for oncology studies through digital solutions 

State-of-the-art technologies enable clinical research projects in oncology to become more patient-centered through digital approaches, leading to a sustainable improvement in the quality of life for cancer patients. 

Let's create an impact. Together. 

The future of oncology research 

By using state-of-the-art technologies such as patient-centered apps, ePRO/eCOA, wearables or telemedicine, we offer you the perfect combination of comprehensive services and innovative technical solutions as a full-service CRO. 

Digitizing Clinical Trials for Oncology

The shift to decentralized and hybrid trial designs enables better collection, analysis and management of data and leads to an improved patient experience by using wearables and patient apps. 

Patient Preference

73% of patients are interested in app-based supportive care during  radiotherapy.  

Physical Activity 

Improvement in patient health through correlation of daily steps and severity of symptoms.

Symptom Tracking 

ePRO-based symptom monitoring improves QoL as well as OS and reduces emergency hospitalization. 

Patient Apps 

80% of healthcare providers consider using app-based reports beneficial. 

Sleep Quality

Physical activity measured and supported by fitness trackers improved sleep quality in breast cancer survivors.

Medication Adherence

A weekly questionnaire on just six clinical parameters makes it possible to detect a relapse at an early stage, on average six weeks earlier.

Telemedicine

Web-based monitoring and self-scored symptoms with clinician follow-up improved OS and QoL in lung cancer patients. 

ePRO/eCOA 

Meta-analyses of 30 studies and 5.3k patients show that app interventions improve QoL and alleviate depression. 

HANSE Study - Digitalization enables decentralization

Alcedis has conducted a lighthouse lung cancer study where >400,000 potential subjects have been approached, >13,000 patients were screened, and 5,191 patients were recruited in 15 months. Subject data, CT scan evaluation and risk scoring were AI-supported. The recruitment campaign was also supported by Social media, Google Ads, personalized mailings and a strong media presence (newspapers, TV).

Streamlined Patient Journey

Online self-registration with a primary self-assessment for eligibility screening, appointment self-booking of low dose CTs in a mobile CT truck.

Recruitment Success

Recruitment was driven by a high level of public visibility and digital accessibility. Over 60% of participants self-registered online, despite the age of the target group (55-79 years old).

Pioneering Approach 

National lung cancer screening program: HANSE study results initiated and supported a national governmental screening program that may already start in 2024.

Trust in our Experience

  • We combine thought leadership with operational excellence focused on scientific results rather than box-ticking.
  • Bringing a high level of academic engagement to deliver the full suite of trial-related services, unlike any traditional contract model. 
Contact Experts

Suitable Technologies

With our strong technological expertise, we are setting new standards in oncology research with our integrated, patient-centered and data-driven platform.

Discover Technologies

Let's create an impact. Together. 

With our comprehensive approach that combines technological innovation and a deep understanding of clinical research, we are ideally positioned to successfully conduct digital clinical trials in the field of oncology.

Contact
We use a selection of our own and third-party cookies on the pages of this website: Essential cookies, which are required in order to use the website; functional cookies, which provide better easy of use when using the website; performance cookies, which we use to generate aggregated data on website use and statistics; and marketing cookies, which are used to display relevant content and advertising. If you choose "ACCEPT ALL", you consent to the use of all cookies. You can accept and reject individual cookie types and revoke your consent for the future at any time at "Settings".